Anesthesiology Doctors in Fort Payne, AL Accepting Medicare

3 Anesthesiology doctors found. Showing 1 - 3

Dr. Bart Onis Barber, DO Anesthesiology - Pain Medicine Medicare: Accepting Medicare Assignments Practice Location: 1600 Gault Ave S, Fort Payne, AL 35967 Phone: 256-979-1972    Fax: 256-979-1974

Asmitha Kathleen Sathiyakumar, MD Anesthesiology - Pain Medicine Medicare: Accepting Medicare Assignments Practice Location: 1403 Old Water Works Rd Sw, Fort Payne, AL 35968 Phone: 256-646-7246

Bart Mitchell Bailey, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 200 Medical Center Drive, Fort Payne, AL 35967 Phone: 256-845-3150

News Archive

FDA approves Medtronic DF4 High-Voltage Connector System for ICDs and CRT-Ds

Medtronic, Inc. today announced the U.S. Food and Drug Administration (FDA) approval and launch of the DF4 High-Voltage Connector System, a right ventricular lead and connector used with implantable cardioverter defibrillators (ICDs) and cardiac resynchronization therapy defibrillators (CRT-Ds) to detect and accurately treat potentially life-threatening heart rhythms.

UCD based healthcare start-up receives funding and plans expansion into US market

A University College Dublin based start-up, THEYA Healthcare (www.theyahealthcare.com), which designs and manufactures healthcare garments, has secured an investment of €665,000.

Convergence starts Phase II proof of concept study with CNV2197944 in pain associated with PHN

Convergence Pharmaceuticals Limited, the company focused on the development of novel and high value analgesic medicines for the treatment of chronic pain, today announces that it has started a Phase II proof of concept study with CNV2197944 in pain associated with post-herpetic neuralgia.

Neoprobe meets with FDA to review Phase 3 clinical trial results of Lymphoseek drug

Neoprobe Corporation, a diversified developer of innovative oncology and surgical diagnostic and treatment products, today announced that it recently met with the United States Food and Drug Administration to review the clinical trial results of a Phase 3 investigational new drug, Lymphoseek®.

Nivolumab, ipilimumab duo effective in poor prognosis advanced melanoma patients

Subgroups of advanced melanoma patients with a poor prognosis derive a progression-free survival benefit from the combination of nivolumab and ipilimumab, according to research presented at the European Cancer Congress in Vienna, Austria.

Read more Medical News

› Verified 2 days ago